Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Editorial: Molecular informatics in precision medicine.
Front Med (Lausanne)
December 2024
Department of Genetic Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Miliary sarcoidosis.
Respirol Case Rep
August 2024
Department of Medicine, Division of Pulmonary and Critical Care Medicine Houston Methodist Hospital Houston Texas USA.
Miliary patterns on chest imaging of the lung can be associated with sarcoidosis.
View Article and Find Full Text PDFA Case of Erythema Nodosum in a 20-Year-Old Female During the Postpartum Period.
Cureus
April 2024
Family Medicine, West Virginia School of Osteopathic Medicine, Lewisburg, USA.
Erythema nodosum (EN) is the most common form of panniculitis and occurs in about one in 100,000 people. EN typically presents as an eruption of tender, erythematous nodules on the anterior aspect of the legs, although the face, trunk, and arms can also be involved. While the majority of cases are idiopathic, a subset of cases occurs in association with various triggers, including infections, medications, tumors, and autoimmune diseases.
View Article and Find Full Text PDFClinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications.
J Clin Med
February 2024
Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY 12208, USA.
When sarcoidosis needs treatment, pharmacotherapy is usually required. Although glucocorticoids work reliably and relatively quickly for sarcoidosis, these drugs are associated with numerous significant side effects. Such side effects are common in sarcoidosis patients, as the disease frequently has a chronic course and glucocorticoid treatment courses are often prolonged.
View Article and Find Full Text PDFArticle Synopsis
- Immune-mediated inflammatory diseases (IMIDs) can negatively affect maternal health during pregnancy, but there is limited research on this topic, especially regarding patients with existing comorbidities.
- * A retrospective cohort study was conducted using a large healthcare system database, analyzing pregnant individuals from 2013 to 2022 to assess the impact of 12 IMIDs on adverse pregnancy outcomes like preterm birth and low birth weight.
- * The study included 365,075 participants, revealing that the prevalence of pregnancies in individuals with IMIDs has doubled over the last decade, with 17% of the IMIDs group receiving prenatal immunomodulatory medication.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!